A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Experimental Treatment Gaining Popularity Online
The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to message these accounts privately for source information, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where communities with thousands of members share comparison images, injection guides and claims of next-day UK delivery. Vendors promote the substance there before redirecting customers to WhatsApp for transactions.
Learning About The Experimental Drug
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.
Medical Professionals Express Concerns
However, doctors and pharmacists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is worrisome and could result in users administering substances of uncertain source.
Some experts said the demand for retatrutide could be linked to the increasing price of approved slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some influencers try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach pharmaceutical, marketing, and customer regulations, risking fines, legal action or imprisonment.
Platform Reaction and Content Elimination
According to TikTok, the platform has taken down violative content and prohibited related keywords and query recommendations. The organization stated it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.
Digital Marketplace Activities
Investigations also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up groups with numerous of users, filled with photos of weight loss, positive testimonials and detailed instructions for mixing or administering at home.
After moments of joining one group, a vendor posted WhatsApp details, where the majority of purchases take place. The seller provided an guidebook and guaranteed delivery within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about weight, medical conditions or past usage.
Product Information and Costs
Inside these groups, messages show black plastic parcels with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at residence with sterile water, or pre-filled pens usually sold at £160 for 20mg. When questioned how much time a injector should be used, vendors give conflicting responses varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for Telegram said it actively monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are administering substances they can’t verify. Although the science behind retatrutide is sound, these digital products may not include what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in demand to current cost increases for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she explained.
Her staff has already encountered patients harmed by self-injection from unverified sources. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject patients to possibly serious health risks”.
